Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-07-19
2011-07-19
Cheu, Jacob (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C436S518000
Reexamination Certificate
active
07981627
ABSTRACT:
A method of diagnosing a liver disorder in a subject is disclosed. The method comprises determining a level of sH2A and at least one additional liver marker in a sample of the subject wherein a change beyond a predetermined threshold in both the sH2A and the at least one additional marker with respect to a sample from a healthy individual is indicative of the liver disorder. Kits for diagnosing a liver disorder are also disclosed.
REFERENCES:
patent: 4036945 (1977-07-01), Haber
patent: 4331647 (1982-05-01), Goldenberg
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 2006/0286615 (2006-12-01), Lederkremer et al.
patent: 0773289 (1996-08-01), None
patent: WO 2004/081029 (2004-09-01), None
Negi et al. Arch. Surg. 2004 vol. 139, p. 299-303.
Official Action Dated Aug. 1, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/224,148.
Official Action Dated Feb. 7, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/224,148.
Communication Pursuant to Article 94(3) EPC Dated Aug. 21, 2009 From the European Patent Office Re.: Application No. 04720548.9.
International Preliminary Report on Patentability Dated Jun. 26, 2008 From the International Bureau of WIPO Re.: Application No. PCT/IL2004/000244.
International Search Report Dated Dec. 18, 2007 From the International Searching Authority Re.: Application No. PCT/IL04/00244.
Invitation to Pay Additional Fees Dated Mar. 14, 2007 From the International Searching Authority Re.: Application No. PCT/IL04/00244.
Official Action Dated Dec. 14, 2007 From the US Patent and Trademark Office.: U.S. Appl. No. 11/224,148.
Official Action Dated Mar. 20, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/224,148.
Official Action Dated Aug. 21, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/224,148.
Response Dated Dec. 16, 2009 to Communication Pursuant to Article 94(3) EPC of Aug. 21, 2009 From the European Patent Office Re.: Application No. 04720548.9.
Supplementary European Search Report Dated Jun. 8, 2009 From the European Patent Office Re.: Application No. 04720548.9.
Written Opinion Dated Dec. 18, 2007 From the International Searching Authority Re.: Application No. PCT/IL04/00244.
Bischoff et al. “The H1 and H2 Polypeptides Associate to Form the Asialoglycoprotein Receptor in Human Hepatoma Cells”, The Journal of Cell Biology, XP007898593, 106(4): 1067-1974, Apr. 1988. p. 1068, l-h Col., Last §-r-h Col., § 1.
Campbell “General Properties and Applications of Monoclonal Antibodies”, Monoclonal Antibody Technology, Elsevier Science Publishers, Chap.1: 1-32, 1984. p. 29.
Doyle et al. “Plasma Membrane: Biogenesis and Turnover”, The Liver: Biology and Pathobiology, 2nd Ed.(Chap.8): 141-163, 1988.
Drickamer “Clearing Up Glycoprotein Hormones”, Cell, 67: 1029-1032, 1991.
Gopal et al. “Abnormal Findings on Liver Function Tests: Interpreting Results to Narrow the Diagnosis and Establish a Prognosis”, Postgraduate Medicine, 107(2): 100-114, 2000.
Hay et al. “The Nature of Unexplained Chronic Aminotransferase Elevations of A Mild to Moderate Degree in Asymptomatic Patients”, Hepatology, 9(2): 193-197, 1989.
Hayasaka et al. “Serum Markers as Tools to Monitor Liver Fibrosis”, Digestion, 59: 381-384, 1998.
Henis et al. “Oligomeric Structure of the Human Asialoglycoprotein Receptor: Nature and Stoichiometry of Mutual Complexes Containing H1 and H2 Polypeptides Assessed by Fluorescence Photobleaching Recovery”, The Journal of Cell Biology, XP007908595, 111(4): 1409-1418, Oct. 1990. p. 1410, r-h Col., § 2-3.
Kokudo et al. “Predictors of Successful Hepatic Resection: Prognostic Usefulness of Hepatic Asialoglycoprotein Receptor Analysis”, Worl Journal of Surgery, XP007908592, 26(11): 1342-1347, Nov. 2002. Abstract.
Lederkremer et al. “An Alternatively Spliced Miniexon Alters the Subcellular Fate of the Human Asialglycoprotein Receptor H2 Subunit”, The Journal of Biological Chemistry, 266(2): 1237-1244, 1991.
Moseley “Evaluation of Abnormal Liver Function Tests”, Management of Chronic Liver Disease, 80(5): 887-906, 1996.
Tolchinsky et al. “Membrane-Bound Versus Secreted Forms of Human Asialglycoprotein Receptor Subunits”, The Journal of Biological Chemistry, XP008101635, 271(24): 14496-14503, 1996.
Trojan et al. “Serum Tests for Diagnosis and Follow-Up of Hepatocellular Carcinoma After Treatment”, Digestion, 59(Suppl.2): 72-74, 1998.
Wisdom “Enzyme-Immunoassay”, Clinical Chemistry, 22(8): 1243-1255, 1976.
Yago et al “Detection and Quantification of Soluble Asialglycoprotein Receptor in Human Serum”, Hepatology, XP000892931, 21(2): 383-388, Feb. 1, 1995.
Notice of Allowance Dated Jan. 15, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/224,148.
Response Dated Nov. 19, 2009 to Official Action of Aug. 21, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/224,148.
Translation of Office Action Dated Apr. 14, 2010 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 200480013005.2.
Response Dated Jul. 21, 2010 to Office Action of Apr. 14, 2010 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 200480013005.2.
Communication Pursuant to Article 94(3) EPC Dated Nov. 18, 2010 From the European Patent Office Re.: Application No. 04720548.9.
Cheu Jacob
Ramot at Tel-Aviv University Ltd.
LandOfFree
Methods for diagnosing and monitoring liver diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for diagnosing and monitoring liver diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for diagnosing and monitoring liver diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2688336